Geneos Wealth Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-128
Closed -$6.59K – 3120
2025
Q2
$6.59K Hold
128
– – ﹤0.01% 2484
2025
Q1
$7.5K Buy
128
+12
+10% +$813 ﹤0.01% 2379
2024
Q4
$8.36K Hold
116
– – ﹤0.01% 2115
2024
Q3
$9.27K Buy
+116
New +$8.72K ﹤0.01% 1866
2022
Q2
– Sell
-8,000
Closed -$866K – 2787
2022
Q1
$866K Hold
8,000
– – 0.04% 398
2021
Q4
$1.03M Hold
8,000
– – 0.04% 387
2021
Q3
$987K Hold
8,000
– – 0.04% 387
2021
Q2
$899K Sell
8,000
-84
-1% -$8.84K 0.04% 393
2021
Q1
$863K Sell
8,084
-8,000
-50% -$730K 0.02% 465
2020
Q4
$1.52M Buy
16,084
+6,544
+69% +$474K 0.06% 271
2020
Q3
$576K Sell
9,540
-4,000
-30% -$260K 0.03% 398
2020
Q2
$868K Hold
13,540
– – 0.05% 306
2020
Q1
$624K Hold
13,540
– – 0.04% 335
2019
Q4
$739K Sell
13,540
-1,000
-7% -$52.5K 0.04% 355
2019
Q3
$717K Hold
14,540
– – 0.04% 338
2019
Q2
$757K Hold
14,540
– – 0.05% 322
2019
Q1
$721K Hold
14,540
– – 0.05% 329
2018
Q4
$515K Sell
14,540
-220
-1% -$9.19K 0.04% 364
2018
Q3
$753K Hold
14,760
– – 0.05% 310
2018
Q2
$545K Hold
14,760
– – 0.04% 316
2018
Q1
$557K Sell
14,760
-260
-2% -$9.19K 0.05% 286
2017
Q4
$486K Hold
15,020
– – 0.04% 322
2017
Q3
$453K Hold
15,020
– – 0.05% 323
2017
Q2
$441K Hold
15,020
– – 0.05% 318
2017
Q1
$381K Sell
15,020
-28
-0.2% -$723 0.04% 333
2016
Q4
$386K Hold
15,048
– – 0.05% 305
2016
Q3
$411K Sell
15,048
-92
-0.6% -$2.53K 0.06% 284
2016
Q2
$424K Hold
15,140
– – 0.06% 275
2016
Q1
$361K Buy
+15,140
New +$333K 0.06% 298

Other funds holding TECH

Geneos Wealth Management's TECH Position: Q3 2025 in Review

Geneos Wealth Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 128 shares — an estimated $6.59K sold.

Geneos Wealth Management first reported a position in TECH in Q1 2016 and held it in 29 quarters. The position peaked at $1.52M in Q4 2020. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Geneos Wealth Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 128 Bio-Techne shares in Q3 2025, an estimated $6.59K.
  • Geneos Wealth Management first reported a position in Bio-Techne in Q1 2016 and held it in 29 quarters.
  • Geneos Wealth Management's Bio-Techne position peaked at $1.52M in Q4 2020.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.